Navigation Links
Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
Date:7/20/2008

he co-develops and markets Genentech products outside North America.

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2007, sales by the Pharmaceuticals Division totaled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested over 8 billion Swiss francs in R&D in 2007. Worldwide, the Group employs about 80,000 people. Additional information is available on the Internet at http://www.roche.com.

All mentioned trademarks are legally protected.

Media Conference

Roche will host a media conference at its headquarters in Basel (Grenzacherstrasse, Research Building 92) on Monday, July 21 at 10:00 a.m. CET. The conference will be broadcast on http://www.roche.com. A replay of the webcast will be archived on the website.

Video Interview with Franz B. Humer

An interview with Franz Humer can be viewed at http://www.roche.com and http://www.transactioninfo.com/roche/. Broadcast media w
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Roche Extends Tender Offer for Ventana
3. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
4. Roche Real-Time HIV Test is Faster and Less Labor-Intensive Than Competitors
5. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. Med Ad News Honors Roche as Company of the Year
8. MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
9. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
10. Phase I Results Announced for R1507 From Genmabs Collaboration With Roche
11. Kosan to Reacquire Epothilone Program From Roche

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , CALGARY and BLENHEIM, Ontario, Nov. 24 /PRN...unced today it is acquiring the assets of Hyland S... Ontario. The addition of Hyland Seeds will furthe...as the company anticipates the introduction of Sm...icide Tolerant Trait Technology in corn in 2012. T...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCall...ll be presenting at the NASDAQ OMX conference on T...5 AM US/CST. Interested parties may listen via liv... http://inve s tor.sig m a a ldrich.com/ . ... file. ,, About Sigma-Aldrich: Sigma-Aldr...
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novemb...nc. (Nasdaq: DCGN ) today announced the approval o...uptcy Court for the District of Delaware,(the "Ban...y petition for,relief under Chapter 11 of the Unit...t. , The orders issued by the Bankruptcy ...
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire-...biopharmaceutical company focused on developing an... announced today that Anthony DiTonno, President a...t at the 21st Annual Piper Jaffray Health Care Con...York Palace Hotel in New York, New York. ,, Mr...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...angamo BioSciences, Inc. (Nasdaq: SGMO ), the wo... finger DNA-binding proteins (ZFPs), announced tod...ges Explorations grant from the Bill & Melinda...vative global health research project conducted by...ses for In Vivo Treatment of HIV Infection." , ...
... Senesco Technologies, Inc. ("Senesco" or the "Co...al results for the three months ended March 31, 20...ed March 31, 2009 was $1,331,477, or $0.07 per sha...08 per share, for the three month period ended Mar...ily the result of a decrease in operating expenses...
...tion, Inc. (Nasdaq: MDVN ) today announced tha...anagement to discuss first quarter 2009 financial ...onday, May 11, 2009, at 4:30 p.m. Eastern Time. A...1, 2009 will be released after markets close on Ma...81-3376 from the U.S. or +1-719-325-4757 internati...
Other Biology Technology:Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 2Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 3Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 4Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 2Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 3Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 4Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 5Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 6Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 7Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009 2
(Date:11/24/2009)... The Lupus Research Institute (LRI) today named 12...ng $3.6 million, recognize innovative work across ...ted for their creativity, novelty, and potential t..., treat, and cure the complex disease of systemic ...blished lupus researchers across the nation and in...
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fro... six months, those stents are no longer needed -- ...necessary. Previously, doctors had no choice but t...of Tel Aviv University,s Department of Biomedical ...er platform that carries drugs where they,re neede...
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- T...oday a report revealing that the last remaining po...gnificantly due to the rising tide of poaching and... will help inform Russian officials of what needs ... world,s biggest cat. , The report ...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Report shows dramatic decline in Siberian tigers 2InfoLogix Achieves Motorola Enterprise Mobility Validation 54799 1InfoLogix Achieves Motorola Enterprise Mobility Validation 54799 2InfoLogix Achieves Motorola Enterprise Mobility Validation 54799 3Uninsured Patients to Receive Free Surgeries Procedures 54795 1Uninsured Patients to Receive Free Surgeries Procedures 54795 2Uninsured Patients to Receive Free Surgeries Procedures 54795 3Uninsured Patients to Receive Free Surgeries Procedures 54795 4Hospitals Reduce Heart Attack Deaths 54790 1Hospitals Reduce Heart Attack Deaths 54790 2Hospitals Reduce Heart Attack Deaths 54790 3
...University’s Massey Cancer Center studying the int...s have identified interferon gamma as one of the s...he findings may help researchers develop tailored ... fight a number of cancers. Immunotherapy involves...cing an antibody or lymphocytes, or immunization w...
...of Genes & Development, Dr. Karlene Cimprich a...ed the minimal DNA structure sufficient to activat...re very excited about these results," says Dr. Cim...late the nature of the checkpoint activating struc...ontrol, quantitative and probe checkpoint signalin...
...eserve grapes could help prevent allergies and boo...nifer Rohn in Chemistry & Industry, the magazi... the wine-making process to produce healthier wine...a and other conditions in some people. , Mass-mar...are usually treated with sulphur dioxide to preven...
Other Biology News:Mechanisms involved with tumor relapse identified 2Grape expectations for healthier wine 2
... a Voltage Clamp, as a Current Clamp or as a Condu...ch applications. Performance in any one mode is as... This amazing instrument is made possible by very ...nal Processing (DSP) integrated circuit chips. Unt...
7500 Series ICP-MS ChemStation Upgrade from Agilent Technologies
... microRNA expression profiling and built on the fl...ynthesis platform. These microarrays are available...Profiling Service. Probe Content The Soil Nemat...matode microRNAs (114 unique mature sequences). Th...
...to the maintenance of appropriate levels of short-...erse as those involved in cellular metabolism, hea... modulation of cell surface receptors and ion chan...gnalling factors. The ubiquitin-proteasome pathwa...
Biology Products: